Previous 10 | Next 10 |
Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named the Post-Script Engagement, Phreesia’s new medication adherence solution, to its list of 2023 Most Innovative Marketing Technologies or Services. Over the last decade, PM360’...
2024-01-10 16:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-04 11:59:40 ET Summary Phreesia's revenue in 3Q24 exceeded expectations, driven by growth in subscriptions, network solutions, and payment processing. The company's fundamentals remain strong, with a long ARPU expansion runway, indicating continued growth potential. Ma...
2023-12-13 13:37:28 ET More on AmWell, Teladoc, etc. Teladoc: High Stock Compensation Is An Issue Teladoc: No Floor Yet Teladoc's Valuation Proposition: 7x EBITDA In 2024, Not So Bad Global telemedicine market to hit $450B in 2032: report American Wel...
2023-12-07 11:16:12 ET Summary Phreesia's stock jumped 21.2% after reporting earnings for FY2024 Q3, indicating a potential bottom for the stock. The company's decision to prioritize profitability over revenue growth has paid off, with a path to profitability supporting the case f...
Phreesia, Inc. (NYSE: PHR) is one of today's top gainers. The company's shares have moved -0.48% on the day to $12.39. Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suit...
2023-12-06 10:00:30 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Biocryst Pharm...
2023-12-05 20:04:05 ET Phreesia, Inc. (PHR) Q3 2024 Earnings Call Transcript December 05, 2023 05:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Ryan Daniels - Willi...
2023-12-05 16:06:52 ET More on Phreesia Phreesia: Share Price Dip Is A Buying Opportunity Phreesia, Inc. (PHR) Q2 2024 Earnings Call Transcript Phreesia, Inc. 2023 Q2 - Results - Earnings Call Presentation Phreesia Q3 2024 Earnings Preview Phreesia sa...
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2023. "I am proud of our work during the third quarter to further our mission of helping patients take a more active role in their care," sai...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 22:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-13 23:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A new survey in partnership with the National Kidney Foundation finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health New research published in The American Journal of ...